Evaluation of cats treated with robenacoxib after gastrointestinal surgery.

IF 1.9 2区农林科学 Q2 VETERINARY SCIENCES

Journal of Feline Medicine and Surgery Pub Date : 2024-11-01 DOI:10.1177/1098612X241277024

Joseph B Rogers, Allison S Mazepa, Kathryn L Kaufman, Bishoy S Eskander, Andrew H Jackson

{"title":"Evaluation of cats treated with robenacoxib after gastrointestinal surgery.","authors":"Joseph B Rogers, Allison S Mazepa, Kathryn L Kaufman, Bishoy S Eskander, Andrew H Jackson","doi":"10.1177/1098612X241277024","DOIUrl":null,"url":null,"abstract":"Objectives: The aim of the study was to determine if cats administered robenacoxib immediately after gastrointestinal surgery have a similar complication rate to cats that were not administered robenacoxib.Methods: Medical records were reviewed for 154 cats that underwent gastrointestinal surgery between December 2015 and September 2021 in this retrospective study. Data collected included patient signalment, presenting complaint, surgical procedure(s) performed, robenacoxib administration and major postoperative complications. Cats were excluded if they did not have a 2-week postoperative follow-up examination. Two groups were analyzed: group R (postoperative robenacoxib administration) consisted of 43 cats; and group C (no postoperative robenacoxib administration) consisted of 111 cats.Results: Complications occurred in 10/43 (23.2%) cats in group R and 34/111 (30.6%) cats in group C. Major complications occurred in 1/43 (2.3%) in group R and 14/111 (12.6%) in group C. Minor complications occurred in 9/43 (20.9%) cats in group R and 20/111 (18.0%) cats in group C. One of 43 cats (2.3%) in group R and 10/111 (9.0%) cats in group C were euthanized or died within 0-16 days after gastrointestinal surgery.Conclusions and relevance: Cats that were administered robenacoxib postoperatively did not have an increase in major postoperative complications after gastrointestinal surgery compared with cats that were administered an alternative analgesic medication. The use of robenacoxib in cats after gastrointestinal surgery may be a safe analgesic option for postoperative pain control.","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"26 11","pages":"1098612X241277024"},"PeriodicalIF":1.9000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11565630/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Feline Medicine and Surgery","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1177/1098612X241277024","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: The aim of the study was to determine if cats administered robenacoxib immediately after gastrointestinal surgery have a similar complication rate to cats that were not administered robenacoxib.

Methods: Medical records were reviewed for 154 cats that underwent gastrointestinal surgery between December 2015 and September 2021 in this retrospective study. Data collected included patient signalment, presenting complaint, surgical procedure(s) performed, robenacoxib administration and major postoperative complications. Cats were excluded if they did not have a 2-week postoperative follow-up examination. Two groups were analyzed: group R (postoperative robenacoxib administration) consisted of 43 cats; and group C (no postoperative robenacoxib administration) consisted of 111 cats.

Results: Complications occurred in 10/43 (23.2%) cats in group R and 34/111 (30.6%) cats in group C. Major complications occurred in 1/43 (2.3%) in group R and 14/111 (12.6%) in group C. Minor complications occurred in 9/43 (20.9%) cats in group R and 20/111 (18.0%) cats in group C. One of 43 cats (2.3%) in group R and 10/111 (9.0%) cats in group C were euthanized or died within 0-16 days after gastrointestinal surgery.

Conclusions and relevance: Cats that were administered robenacoxib postoperatively did not have an increase in major postoperative complications after gastrointestinal surgery compared with cats that were administered an alternative analgesic medication. The use of robenacoxib in cats after gastrointestinal surgery may be a safe analgesic option for postoperative pain control.

查看原文本刊更多论文

对胃肠道手术后使用罗本昔布治疗的猫进行评估。

研究目的该研究旨在确定胃肠道手术后立即服用罗苯昔布的猫的并发症发生率是否与未服用罗苯昔布的猫相似：在这项回顾性研究中，对 2015 年 12 月至 2021 年 9 月期间接受胃肠道手术的 154 只猫的医疗记录进行了审查。收集的数据包括患者信号、主诉、手术过程、罗朋那考昔用药情况和主要术后并发症。未进行术后两周随访检查的猫咪将被排除在外。共分两组进行分析：R组（术后使用罗苯昔布）包括43只猫咪；C组（术后未使用罗苯昔布）包括111只猫咪：R组有10/43（23.2%）只猫出现并发症，C组有34/111（30.6%）只猫出现并发症。R组有1/43（2.3%）只猫出现主要并发症，C组有14/111（12.6%）只猫出现轻微并发症。R 组 43 只猫中有 1 只（2.3%）和 C 组 10/111 只（9.0%）在胃肠道手术后 0-16 天内安乐死或死亡：与使用其他镇痛药物的猫相比，术后使用罗苯昔布的猫在胃肠道手术后的主要并发症并没有增加。在猫咪胃肠道手术后使用罗苯昔布可能是一种安全的术后止痛选择。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Feline Medicine and Surgery 农林科学-兽医学

CiteScore

3.90

自引率

17.60%

发文量

254

审稿时长

8-16 weeks

期刊介绍： JFMS is an international, peer-reviewed journal aimed at both practitioners and researchers with an interest in the clinical veterinary healthcare of domestic cats. The journal is published monthly in two formats: ‘Classic’ editions containing high-quality original papers on all aspects of feline medicine and surgery, including basic research relevant to clinical practice; and dedicated ‘Clinical Practice’ editions primarily containing opinionated review articles providing state-of-the-art information for feline clinicians, along with other relevant articles such as consensus guidelines.